ema glp-1 vision loss recommendation october 2025 Receptor Agonists and risk Novo's Ozempic linked to rare
Description
Richard Perugini, the Director of Bariatric Surgery at the UMass Memorial Medical Center Weight Center, joined WFXT Boston 25 News to explain how patients are now improving their results by adding GLP-1 medications to their bariatric surgery treatment plans.
CVS Caremark dropped Zepbound in July 2025, affecting 200K+ patients
Natural Ingredient Synergy
Stopping GLP-1 medications like Wegovy often leads to significant weight regain within months
Companies are investing in research and development
